Are you expecting?
Whether you’re newly pregnant or planning a pregnancy, you might be wondering about prenatal testing for chromosome conditions. A simple blood draw can give you information about the probability of certain chromosome conditions from as early as 9 weeks into the pregnancy. Finding out about the chance of having these before birth can give parents and their healthcare team early information which can help with managing the pregnancy, birth, and ongoing care.
Why NIPT?
Panorama non-invasive prenatal test (NIPT) is a simple blood test, taken from the mother during the pregnancy, that can screen for some of the most common chromosome conditions, such as Down syndrome or Edwards syndrome. Other conditions, for example 22q11.2 deletion syndrome, are less well-known than Down syndrome but may have important consequences for the baby’s health.
NIPT uses genetic analysis to tell you about the probability of your baby having one of the conditions screened for. Your healthcare professional can help you to understand the results, which would be used with other information from your pregnancy such as ultrasound scans to guide management of your pregnancy and decide whether further tests are needed.
Watch our video: Panorama – For you and your baby
Non-invasive prenatal testing (NIPT) is a screening test which provides substantially fewer incorrect results than maternal serum screening or other prenatal blood tests for common chromosome conditions. This is important because high probability results from screening tests are not definitive and would usually be confirmed with an invasive diagnostic procedure, which carries an increased risk of miscarriage. Having a more accurate screening test means that less women are incorrectly told that their baby has an increased probability of having a chromosome condition. This means that less women are faced with the decision to undergo an invasive diagnostic procedure. It is important to understand that a low probability result on screening does not completely eliminate the risk of your baby having the conditions screened for.
To better understand NIPT
https://panorama-test-uk.co.uk/
Disclaimer
Panorama TM is a non-invasive prenatal test (NIPT) based on cell-free DNA analysis and is considered a prenatal screening test, not a diagnostic test. Before making any treatment decisions, all women should discuss their results with their healthcare provider, who can recommend confirmatory, diagnostic testing where appropriate. The test described has been developed and its performance characteristics determined by the CLIA-certified laboratory performing the test. The test has not been cleared or approved by the US Food and Drug Administration (FDA). Although FDA is exercising enforcement discretion of premarket review and other FDA legal requirements for laboratory-developed tests in the US, certification of the laboratory is required under CLIA to ensure the quality and validity of the tests. CAP accredited, ISO 13485 certified, and CLIA certified © 2021 Natera, Inc. All Rights Reserved.
